Report an error

Spotted something inaccurate in “Casdatifan Targets HIF-2α in Kidney Cancer With Once-Daily Oral Dosing”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.